BioVentix Posts Marginal Increase In FY26 Profit Before Tax; Shares Drop

BioVentix PLC (BVXP.L), a UK-based biotechnology company, on Monday recorded a marginal increase in fiscal 2026 profit before tax, driven mainly by its Neuro segment royalties and lower expenses, despite slightly lower revenues.